| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |